Certis Biologicals
Classification
Private
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
About
About
Certis Biologicals is a biotechnology company founded in 2001 by Mitsui & Co. through the acquisition of Thermo Trilogy Corporation, with its headquarters located in Columbia, Maryland. The company traces its origins to the mid-1990s development of biological and botanical pesticides, including the formation of Thermo Trilogy in 1996 and the acquisition of Neem Technologies from W.R. Grace. It rebranded from Certis USA to Certis Biologicals in 2021 to emphasize its focus on biological innovations and global distribution of biopesticides. Business/Product Breakdown Certis Biologicals develops, manufactures, and distributes biopesticides and related biological solutions for organic and conventional crop protection, targeting pests, diseases, and weeds in commercial agriculture, turf, greenhouses, and home and garden applications. The portfolio includes biofungicides and bactericides such as Convergence, Double Nickel, Howler EVO, and KOCIDE 3000-O for controlling fungal and bacterial diseases through mechanisms like rhizosphere colonization and microbiome enhancement; biological plant activators like LifeGard WG to trigger plant resistance genes against foliar infections; bionematicides such as NemaClean to target plant-parasitic nematodes across life stages; and bioinsecticides including Bt-based products and neem-derived formulations like Trilogy for insect and mite control. These residue-exempt, OMRI-listed products support integrated pest management programs, offering short re-entry intervals, zero-day pre-harvest intervals, and compatibility with conventional chemistries, while production occurs at three dedicated facilities in the United States and India focused on fermentation and neem extraction. The company exports to more than 50 countries and collaborates with partners like Certis-Belchim for regulatory approvals, Belchim Crop Protection Canada for distribution, and technology providers such as AgBiome and Bayer CropScience to expand solutions for row crops including corn, soybeans, peanuts, fruits, vegetables, and nuts.
Keywords
Keywords
Classified
Private